HLA-E and HLA-H, which are a part of the HLA Class I processing pathway, were among those that showed the greatest differences in CFS in the immune gene GO cluster (Table 3) and could serve as potential markers for future targeted therapeutic studies in CFS. The gene discussed is HLA-E; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.